Santander to start producing legal cannabis, generating millions in revenue

After a long period of waiting, the Colombian province of Santander is ready to develop the cannabis business and help revitalize the South American country’s economy with new plantations. It is expected that, with this development, the province will be able to generate more than $500 million in revenue and become one of the pillars in the Colombian cannabis market.

On 7 hectares of licensed land in Mesa de los Santos (Santander), a local cannabis project is making progress. Next October, the first production of ‘full-spectrum cannabis extract’ will be harvested, which can be used to make pharmaceutical and cosmetic products.

After more than 3 years of work in the company Green Health Colombia, it is estimated that in 5 months they will be able to extract about 40 liters from the cannabis plants which, according to the company Colombia Positiva, could generate annual exports of more than $500 million in the country.

If you want to know more about cannabis, how Santander could become one of the pillars for the Colombian cannabis market, and to find out the latest hemp news, download the Hemp.im mobile application.

Several types of cannabis seeds will be developed in Santander

Several studies around the world have determined that cannabis can be used to treat various diseases, such as psoriasis, glaucoma, epilepsy, Parkinson’s disease and the side effects of chemotherapy used in cancer cases.

Eduardo Enrique Mayorga, founder, and manager of the company that with foreign support has invested $3.56 million (CA$5 million), indicating that two weeks ago they obtained from the National Government the registration for 8 seeds, a key step for the cultivation and commercial extraction.

Five types of seeds have a high component of CBD-(Cannabidiol), which, according to experts, generates benefits for managing anxiety and stress, analgesics, epilepsy treatments, and neurodegenerative diseases.

The remaining three types of seeds contain THC-(Tetrahydrocannabinol) which functions as an antioxidant, anti-inflammatory, analgesic, neuro-protective, and muscle relaxant. In addition, two types of seeds were registered under the names ‘Heaven of the Saints’ and ‘Fortress of the Saints’.

“Colombian law allowed us to produce the seed itself, and in 2018 we asked ICA to register an agronomic evaluation unit that allowed us to study and combine European, North American, and Colombian seeds (60) to analyze their genetics and behavior in the field,” Mayorga added.

After obtaining the registry, the company switched from scientific to commercial planting, registering the seed as the property of the company which, before the COVID-19 health emergency, had generated nearly 90 jobs.

There are currently 40 workers on the land where there are 2,000 square meters of greenhouses for mother plants, 5,000 more for greenhouses and production and 480 square meters for the extraction laboratory.

Colombian cannabis figures point to a bright future

According to Fedesarrollo, before the coronavirus pandemic, the global legal cannabis market was expected to grow from 7% in 2018 to about 44% in 2025.

The number of applications for licenses from small and medium producers is over 4,000 (3,741 from small and medium producers) and 247 cultivation licenses have been issued up to last year. Also approved were 199 registrations with the ICA and 120 licenses for the manufacture of cannabis derivatives.

Juan Camilo Beltrán, executive director of the Bucaramanga Chamber of Commerce, said the cannabis sector “has interesting potential. We would be contributing to improving export indicators in Santander, generating employment, increasing the Gross Domestic Product (GDP) and developing health.

“From the Chamber we intend to promote this type of initiative through associative models that allow us to connect producers and processors with potential investors and customers nationwide, with people interested in developing their own productive initiatives,” added the executive of the entity that would be considering the creation of a ‘cannabis node’ in Santander.

Santander’s climate is perfect for cannabis development

Senator Juan Manuel Galán, the author of the bill that became law and regulated the production of medical cannabis in the country, highlighted the selection of the Mesa de los Santos as the headquarters for the regional project because the climate of the area is ideal for this type of crop.

“The lower the temperature, the less risk for the plants. Many people made a mistake because they saved money on the initial investment and bought land in remote and hot areas. It was a very big boom, there were 400 companies in the race to obtain licenses at the end of the previous government and this generated a traffic jam. ICA had a flood of applications for seed certification,” added the parliamentarian.

The senator, of Santanderean origin, invited the companies to specialize and did not want to deal with all the processes of cannabis.

“That is why in the law we prohibit the possibility of exporting dried flowers, so as not to lose technology transfer, investment in research and laboratories, and to comply with good manufacturing practices that they are demanding in Europe and Canada.”

For the time being, the regional project already has contacts with Brazilian pharmaceutical companies interested in the product. An investment agreement with the Canadian company Cannaverde Pharma was signed, whose main objective is the search for financial resources and promotion abroad, working hand in hand with local universities such as UNAB and UIS and with La Salle and Nacional, in Bogotá.

__

(Featured image by Pexels via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in El Tiempo, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.